The regulatory file for calcium HMB
Calcium HMB is supplied as the calcium salt, CAS 135236-72-5. Three documents answer three different questions: the specification defines the material, the certificate releases a lot against it, and the regulatory file records how the destination market allows it to be sold. The buyer's team confirms that last route, and this page lists what belongs in the folder so the specification and the commercial paperwork can be checked as a set.
One document cannot answer three questions: the specification defines the material, the certificate releases the lot, and the file records what the destination allows.
Four parts of the folder
The folder holds the current specification for the calcium salt, the certificate for the lot on offer, the limits and labelling rules that apply where the finished product will be sold, and a record of how changes to source, process or pack are approved. The COA speaks for one lot, the TDS for the grade and the SDS for handling. None of them decides the destination route, which is a separate sheet in the same folder.
Two HMB-specific lines are easy to lose. The calcium figure is not only an assay check; in the finished product it becomes part of the nutrient declaration, so the file needs the calcium method as well as the number. The assay reference is the other: a certificate that says 99% without saying “as calcium HMB” cannot be matched to a spec or a label. Add the origin record, the allergen and GMO positions, a residual-solvent statement and any declaration the customer's market requires, and list the gaps before the order moves rather than after the ship sails.
European Union
The first EU question is the status of the exact material. Regulation (EU) 2015/2283 governs foods that were not consumed to a significant degree before 15 May 1997, and the novel-food catalogue records how a given substance is classified. Suppliers describe calcium HMB in several ways — long-established ingredient, novel food authorised under the earlier framework, or simply “approved” — and those descriptions are not equivalent. The catalogue entry for the calcium salt is what the buyer's team checks, and the free acid is a separate entry.
Around that status sit the general rules: Regulation (EC) 178/2002 for food law, Regulation (EU) 1169/2011 for labelling, and Regulation (EU) 2023/915 for contaminants as of this review. Meeting the catalogue entry does not by itself meet those texts for the finished product. The EU regulatory notes gather the references.
United States
In the US the question is the basis on which calcium HMB enters a dietary supplement. A GRAS conclusion covers a named use and level, not an ingredient in the abstract, so the supplier's statement should say which use it addresses. For a supplement the route is normally a GRAS basis that reaches the finished product or an accepted new dietary ingredient notification; the buyer's team confirms which one the file relies on and that it covers the article being sold.
Labelling follows the Supplement Facts format, and calcium from the salt appears in the mineral line as well as in the HMB line. Structure/function wording gets its own review, with substantiation and the DSHEA disclaimer. Neither the label review nor the claim review is something a certificate can supply.
United Kingdom
Two regimes share the UK. Great Britain keeps its own register and labelling rules, while Northern Ireland stays inside the EU framework, including the EU position on calcium HMB. The delivery address, not the customer's head office, selects the regime, and the buyer's team should minute that choice alongside the order, so that label and entry can be checked later.
Contaminants and the finished dose
Contaminant limits apply to the supplement as sold, not to the drum. The ingredient result has to be carried through the dose and through the ingredient's share of the formula. A material that is a small fraction of the serving contributes a small fraction of the limit; a material that is most of the serving contributes nearly all of it.
| Element | Usual supplement limit | Evidence the file needs |
|---|---|---|
| Lead (Pb) | 3.0 mg/kg | Lot result, method, limit and the dose calculation |
| Cadmium (Cd) | 1.0 mg/kg | Lot result and any category exception |
| Mercury (Hg) | 0.10 mg/kg | Lot result and method |
| Arsenic (As) | Agreed with the customer or market | The agreed figure and method, printed on the certificate |
These are starting points, not a substitute for the current text. A category exception, a lower national figure or a customer specification can tighten any of them, and the daily dose decides how the ingredient result converts into the finished product.
Claims
In the EU a health claim must appear on the Register of nutrition and health claims; wording that is absent from the Register cannot be used, whatever the ingredient's history. In the US a structure/function statement needs substantiation and the disclaimer. Neither market has room for a disease-related claim, and the vocabulary sports marketing reaches for — recovery, strength, lean mass — is claim language that the brand's reviewer tests against the product, its form and the destination market.
The certificate supports the material, not the wording. A claim revision does not reopen the specification, and a specification change does not authorise a new claim. Keeping the two files apart lets each be reviewed on its own terms.
What the buyer's file should hold
On the analytical side: the certificate with the HPLC assay, its reference and its basis; calcium by titration; loss on drying; the metal panel; the micro count. On the specification side: the version that names the calcium salt and the assay basis, plus the TDS and SDS. On the trade side: origin, allergen and GMO positions, the residual-solvent statement, the stability summary for the pack, the packaging statement and the supplier's statement of market status.
Every one of those documents should carry the same lot code as the pack. The HMB product page carries the catalog specification and the quality page describes how the release file is assembled. The supplier keeps source, process and pack under change control; the buyer adds the destination route, the finished dose and the label review.
Checklist before the first order
- The specification version, CAS number and calcium salt are written out in full.
- Certificate, TDS, SDS, origin, allergen, GMO and residual-solvent papers are in the folder.
- Metal results have been converted to the finished dose.
- The status of the exact salt is recorded, with the free acid recorded separately.
- Label and claim wording have been reviewed for the destination.
- Quotation, specification and certificate cite the same version.
The certificate answers for the lot, the specification answers for the material, and the folder answers for the market. Keeping those roles distinct is what makes an audit survivable.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation